Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gene editing technology
|
| gptkbp:amendedBy |
gptkb:gene
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:deliveredBy |
subretinal injection
|
| gptkbp:developedBy |
gptkb:Editas_Medicine
|
| gptkbp:firstInHuman |
2019
|
| gptkbp:hasCompany |
gptkb:Editas_Medicine
|
| https://www.w3.org/2000/01/rdf-schema#label |
EDIT-101
|
| gptkbp:indication |
inherited retinal disease
|
| gptkbp:mechanismOfAction |
gptkb:CRISPR-Cas9
|
| gptkbp:routeOfAdministration |
ocular
|
| gptkbp:status |
gptkb:clinical_trial
|
| gptkbp:target |
gptkb:Leber_congenital_amaurosis_10
|
| gptkbp:targetGene |
gptkb:CEP290
|
| gptkbp:therapeuticArea |
ophthalmology
|
| gptkbp:bfsParent |
gptkb:Editas_Medicine
|
| gptkbp:bfsLayer |
5
|